Skip to main content
Log in

Muscle Fat Content Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Chinese Adults

  • Original Research
  • Published:
The journal of nutrition, health & aging

Abstract

Objectives

Several studies have linked myosteatosis with nonalcoholic fatty liver disease (NAFLD) in individuals with obesity The clinical significance of myosteatosis in individuals with NAFLD in the general population has not been well investigated. Here, we wanted to explore and compare the associations of NAFLD and liver fibrosis with muscle fat content and skeletal muscle mass (SMM) in a relatively large general population in China.

Methods

We retrospectively included all participants who underwent abdominal CT scans in our health promotion center between April 2021 and October 2021. Muscle fat content was assessed by abdomen quantitative computed tomography (QCT) scans, and SMM was evaluated by bioelectrical impedance. NAFLD was assessed by ultrasonography. The NAFLD fibrosis score (NFS) and Fibrosis-4 Index (FIB-4) score were calculated to assess liver fibrosis.

Results

Compared with participants without NAFLD, patients with NAFLD showed significantly increased intermuscular adipose tissue (IMAT%) (7.40±3.37% vs. 6.76±2.66%, P <0.01). According to a multiple logistic regression model, IMAT% (OR=1.091, 95% CI 1.030–1.155, P=0.003) was only independently correlated with NAFLD in obese participants. Mediation analysis showed that BMI mediated the association between IMAT% and NAFLD. In participants with NAFLD, increased IMAT% was independently associated with an increased intermediate to high risk of advanced fibrosis assessed by the NFS or FIB-4 score after adjusting for multiple potential confounders. However, SMM was only independently correlated with an intermediate to high risk for advanced fibrosis evaluated by the NFS and not by the FIB-4 score.

Conclusion

Increased muscle fat content is positively correlated with NAFLD and intermediate to high risk for advanced fibrosis in the general Chinese population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

Data Availability Statement: The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.

References

  1. Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, et al. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis. Hepatology 2019;70:1119–1133. doi: https://doi.org/10.1002/hep.30702.

    Article  PubMed  Google Scholar 

  2. Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol 2021;18:599–612. doi: https://doi.org/10.1038/s41575-021-00448-y.

    Article  PubMed  Google Scholar 

  3. Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 2020;69:1691–1705. doi: https://doi.org/10.1136/gutjnl-2020-320622.

    Article  CAS  PubMed  Google Scholar 

  4. Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet 2021;397:2212–2224. doi: https://doi.org/10.1016/S0140-6736(20)32511-3.

    Article  CAS  PubMed  Google Scholar 

  5. Younossi ZM, Corey KE, Lim JK. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 2021;160:912–918. doi: https://doi.org/10.1053/j.gastro.2020.11.051.

    Article  PubMed  Google Scholar 

  6. Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, Kang ES, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011). J Hepatol 2015;63:486–493. doi: https://doi.org/10.1016/j.jhep.2015.02.051.

    Article  PubMed  Google Scholar 

  7. Kim G, Lee SE, Lee YB, Jun JE, Ahn J, Bae JC, Jin SM, et al. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. Hepatology 2018;68:1755–1768. doi: https://doi.org/10.1002/hep.30049.

    Article  CAS  PubMed  Google Scholar 

  8. Guo W, Zhao X, Miao M, Liang X, Li X, Qin P, Lu J, et al. Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease. Front Nutr 2022;9:883015. doi: https://doi.org/10.3389/fnut.2022.883015.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Petermann-Rocha F, Gray SR, Forrest E, Welsh P, Sattar N, Celis-Morales C, Ho FK, et al. Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants. J Hepatol 2022;76:1021–1029. doi: https://doi.org/10.1016/j.jhep.2022.01.010.

    Article  CAS  PubMed  Google Scholar 

  10. Kim HK, Kim CH. Quality Matters as Much as Quantity of Skeletal Muscle: Clinical Implications of Myosteatosis in Cardiometabolic Health. Endocrinol Metab (Seoul) 2021;36:1161–1174. doi: https://doi.org/10.3803/EnM.2021.1348.

    Article  PubMed  Google Scholar 

  11. Miljkovic I, Vella CA, Allison M. Computed Tomography-Derived Myosteatosis and Metabolic Disorders. Diabetes Metab J 2021;45:482–491. doi: https://doi.org/10.4093/dmj.2020.0277.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Nachit M, Kwanten WJ, Thissen JP, Op De Beeck B, Van Gaal L, Vonghia L, Verrijken A, et al. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. J Hepatol 2021;75:292–301. doi: https://doi.org/10.1016/j.jhep.2021.02.037.

    Article  CAS  PubMed  Google Scholar 

  13. De Munck TJI, Verhaegh P, Lodewick T, Bakers F, Jonkers D, Masclee AAM, Verbeek J, et al. Myosteatosis in nonalcoholic fatty liver disease: An exploratory study. Clin Res Hepatol Gastroenterol 2021;45:101500. doi: https://doi.org/10.1016/j.clinre.2020.06.021.

    Article  CAS  PubMed  Google Scholar 

  14. Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol 2018;33:70–85. doi: https://doi.org/10.1111/jgh.13857.

    Article  PubMed  Google Scholar 

  15. Sinn DH, Kang D, Kang M, Guallar E, Hong YS, Lee KH, Park J, et al. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study. Hepatology 2022;76:1746–1754. doi: https://doi.org/10.1002/hep.32578.

    Article  CAS  PubMed  Google Scholar 

  16. Peng X, Li X, Xu Z, Wang L, Cai W, Yang S, Liao W, et al. Age-related fatty infiltration of lumbar paraspinal muscles: a normative reference database study in 516 Chinese females. Quant Imaging Med Surg 2020;10:1590–1601. doi: https://doi.org/10.21037/qims-19-835.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cho AR, Lee JH, Kwon YJ. Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study. Life (Basel) 2021;11. doi: https://doi.org/10.3390/life11080751.

  18. Kang MK, Park JG, Lee HJ, Kim MC. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2019;34:1633–1640. doi: https://doi.org/10.1111/jgh.14607.

    Article  CAS  PubMed  Google Scholar 

  19. Gan D, Wang L, Jia M, Ru Y, Ma Y, Zheng W, Zhao X, et al. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr 2020;39:1124–1130. doi: https://doi.org/10.1016/j.clnu.2019.04.023.

    Article  PubMed  Google Scholar 

  20. Hsieh YC, Joo SK, Koo BK, Lin HC, Kim W. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Liver Int 2021;41:494–504. doi: https://doi.org/10.1111/liv.14719.

    Article  CAS  PubMed  Google Scholar 

  21. Han E, Kim MK, Lee HW, Ryu S, Kim HS, Jang BK, Suh Y. Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesity. Obesity (Silver Spring) 2022;30:2440–2449. doi: https://doi.org/10.1002/oby.23576.

    Article  CAS  PubMed  Google Scholar 

  22. Nachit M, De Rudder M, Thissen JP, Schakman O, Bouzin C, Horsmans Y, Vande Velde G, et al. Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models. J Cachexia Sarcopenia Muscle 2021;12:144–158. doi: https://doi.org/10.1002/jcsm.12646.

    Article  PubMed  Google Scholar 

  23. Hsieh YC, Joo SK, Koo BK, Lin HC, Lee DH, Chang MS, Park JH, et al. Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression. Clin Gastroenterol Hepatol 2023;21:388–397.e310. doi: https://doi.org/10.1016/j.cgh.2022.01.020.

    Article  CAS  PubMed  Google Scholar 

  24. Nachit M, Lanthier N, Rodriguez J, Neyrinck AM, Cani PD, Bindels LB, Hiel S, et al. A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients. JHEP Rep 2021;3:100323. doi: https://doi.org/10.1016/j.jhepr.2021.100323.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kim HS, Lee J, Kim EH, Lee MJ, Bae IY, Lee WJ, Park JY, et al. Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography. Diabetes Metab J 2023;47:104–117. doi: https://doi.org/10.4093/dmj.2022.0081.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 2021;320:C375–C391. doi: https://doi.org/10.1152/ajpcell.00379.2020.

    Article  CAS  PubMed  Google Scholar 

  27. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105:141–150. doi: https://doi.org/10.1016/j.diabres.2014.04.006

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We appreciate the help and support from all participants who took part in the study.

Funding

Funding: This study was supported by Jiangsu Province Capability Improvement Project through Science, Technology and Education (ZDXK202248) National Natural Science Foundation of China Youth Fund (82200946), and Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University (No. PY2021008).

Author information

Authors and Affiliations

Authors

Contributions

Author contributions: Wen Guo, Shuang Hu and Qun Zhang participated in the study design. Wen Guo, Xin Zhao, Dan Cheng, Xiuru Liang, Mengyuan Miao, Xiaona Li, Jing Lu, and Nianzhen Xu were involved in the conduct of the study and data collection. Wen Guo and Shuang Hu participated in the data analysis. Wen Guo and Qun Zhang wrote and modified the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Shuang Hu or Qun Zhang.

Ethics declarations

Declaration of competing interest: The authors declare that they have no conflicts of interest.

Additional information

Institutional Review Board Statement: The study protocol was approved by the Human Research Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (2023-SR-048).

Informed Consent Statement: The requirement for informed consent was waived by the ethics committee, because this study was designed to retrospectively collect available data from the participants’ physical examination results.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, W., Zhao, X., Cheng, D. et al. Muscle Fat Content Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Chinese Adults. J Nutr Health Aging 27, 960–965 (2023). https://doi.org/10.1007/s12603-023-2015-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-023-2015-9

Key words

Navigation